Results 161 to 170 of about 149,597 (269)

Nanographene-Based van der Waals Organic Framework With Permanent Porosity. [PDF]

Angew Chem Int Ed Engl
Oró A, Turo-Cortés R, Perles J, Costa JS, Fernández-García JM, Martín N.   +5 more
europepmc   +1 more source

Formation Plan de Gestion des Données (PGD)

, 2018
Auzoux, Sandrine, Corbiere, Pauline, Dedieu, Laurence, Paradis, Sébastien   +3 more
openaire   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Nb-Doped VO₂-Based Coatings on Glass: Substrate Effects, Thermochromic Performance, and an Effective Transition Temperature for Smart-Glazing Applications. [PDF]

ACS Appl Mater Interfaces
Santos AJ, Casas-Acuña A, Mánuel JM, Jiménez JJ, Obrero-Pérez JM, Benedetto D, Martin N, Morales FM.   +7 more
europepmc   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

Role of WDR66 in Stemness, Therapy Resistance and Tumor microenvironment modulation in Head and Neck Cancer. [PDF]

Int J Biol Sci
Sanchez-Diaz L, Espinosa-Sánchez A, Carnero A.   +2 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

SR-B1 knockdown suppresses breast cancer cell proliferation, migration, and invasion via the PI3K/AKT pathway. [PDF]

Einstein (Sao Paulo)
Li M, Xu Y, Li J, Li J.
europepmc   +1 more source

Plan de formation de l'équipe d'animation

openaire   +1 more source